[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69815659D1 - Zusammensetzung zur kontrollierten freisetzung - Google Patents

Zusammensetzung zur kontrollierten freisetzung

Info

Publication number
DE69815659D1
DE69815659D1 DE69815659T DE69815659T DE69815659D1 DE 69815659 D1 DE69815659 D1 DE 69815659D1 DE 69815659 T DE69815659 T DE 69815659T DE 69815659 T DE69815659 T DE 69815659T DE 69815659 D1 DE69815659 D1 DE 69815659D1
Authority
DE
Germany
Prior art keywords
composition
controlled release
active material
biologically active
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69815659T
Other languages
English (en)
Other versions
DE69815659T2 (de
Inventor
Kare Larsson
Helena Ljusberg-Wahren
Niels Krog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandberg Development AB
Original Assignee
GS Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GS Development AB filed Critical GS Development AB
Publication of DE69815659D1 publication Critical patent/DE69815659D1/de
Application granted granted Critical
Publication of DE69815659T2 publication Critical patent/DE69815659T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69815659T 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung Expired - Lifetime DE69815659T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
SE9700061 1997-01-13
PCT/SE1998/000009 WO1998030206A1 (en) 1997-01-13 1998-01-08 Controlled release composition

Publications (2)

Publication Number Publication Date
DE69815659D1 true DE69815659D1 (de) 2003-07-24
DE69815659T2 DE69815659T2 (de) 2004-04-29

Family

ID=20405393

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69815659T Expired - Lifetime DE69815659T2 (de) 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung

Country Status (9)

Country Link
US (1) US6660278B1 (de)
EP (1) EP0954287B1 (de)
JP (1) JP2001508773A (de)
AT (1) ATE243024T1 (de)
AU (1) AU5583298A (de)
CA (1) CA2277377C (de)
DE (1) DE69815659T2 (de)
SE (1) SE511313C2 (de)
WO (1) WO1998030206A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
PL211116B1 (pl) * 2001-10-19 2012-04-30 Idexx Lab Komozycja do podawania ssakowi związku farmakologicznie czynnego i sposób wytwarzania preparatu do wstrzyknięć
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
NZ551990A (en) * 2004-06-04 2011-01-28 Camurus Ab Liquid depot formulations
US8001922B2 (en) 2004-09-28 2011-08-23 Atrium Medical Corporation Application of a coating on a medical device
EP1811933B1 (de) 2004-09-28 2016-03-23 Atrium Medical Corporation Barriereschicht
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
EP1933991A4 (de) 2005-10-15 2012-05-02 Atrium Medical Corp Hydrophobe vernetzte gele für bioabsorbierbare arzneimittelträgerüberzüge
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
EP2083875B1 (de) 2006-11-06 2013-03-27 Atrium Medical Corporation Beschichtetes chirurgisches netz
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
US8603999B2 (en) 2008-12-05 2013-12-10 Commonwealth Scientific And Industrial Research Organisation Amphiphile prodrugs
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011050388A1 (en) * 2009-10-30 2011-05-05 Monash University Liquid crystal composition and method of use
WO2011145659A1 (ja) * 2010-05-18 2011-11-24 富士フイルム株式会社 カロチノイド含有組成物及びその製造方法
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
CN104661648B (zh) 2012-07-26 2019-04-05 卡姆拉斯公司 阿片样物质制剂
UA128186C2 (uk) 2017-11-27 2024-05-01 Умекрайн Когнішн Аб ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ 3<font face="Symbol">a</font>-ЕТИНІЛ-3<font face="Symbol">b</font>-ГІДРОКСІАНДРОСТАН-17-ОНУ ОКСИМУ
JP2021527675A (ja) 2018-06-21 2021-10-14 ナノメッド ホールディングス プロプライエタリー リミテッド プラチナベースの両親媒性プロドラッグ
CN116867376A (zh) * 2021-01-29 2023-10-10 Ioi油脂化学品有限责任公司 含有聚甘油脂肪酸酯的组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (de) * 1974-10-19 1978-07-03
US5264460A (en) * 1988-05-30 1993-11-23 Deutsche Solvay-Werke Gmbh Process for preparing nonionic surfactants
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
IE921212A1 (en) 1991-04-19 1992-10-21 Affinity Biotech Inc Convertible microemulsion formulations
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US6013269A (en) * 1994-10-12 2000-01-11 The Procter & Gamble Company Cosmetic make-up compositions
SE504582C2 (sv) 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
EP0954287A1 (de) 1999-11-10
ATE243024T1 (de) 2003-07-15
US6660278B1 (en) 2003-12-09
WO1998030206A1 (en) 1998-07-16
AU5583298A (en) 1998-08-03
SE9700061D0 (sv) 1997-01-13
SE9700061L (sv) 1998-07-14
SE511313C2 (sv) 1999-09-06
CA2277377A1 (en) 1998-07-16
CA2277377C (en) 2007-12-18
EP0954287B1 (de) 2003-06-18
JP2001508773A (ja) 2001-07-03
DE69815659T2 (de) 2004-04-29

Similar Documents

Publication Publication Date Title
ATE243024T1 (de) Zusammensetzung zur kontrollierten freisetzung
ES2153355T3 (es) Procedimiento para la preparacion de microesferas que contienen compuestos biologicamente activos.
TR199701277T1 (xx) Biyoaktif bile�ikler olarak ya� asidi esterleri.
BG93040A (bg) Метод за дрбиване на нефт от нефтени находища
IL106248A (en) Adhesive compositions and method of bonding biological tissue to a substance
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
AU561811B2 (en) Organic amide compounds derived from nitrogenous lipids
EP0152281A3 (de) Transdermale Nicardipinhydrochlorid-Formulierung
BR9808668A (pt) Suspensão aquosa de microcápsulas compreendendo um material biologicamente ativo, e, processos para preparação de uma suspensão aquosa de microcápsulas aderentes e para aplicação de microcápsulas em um substrato pretendido
ES2042700T3 (es) Composiciones farmaceuticas con liberacion controlada, y metodo para su preparacion.
DE69531864D1 (de) Indolizin spal2 inhibitoren
MY110984A (en) Immobilized lipases
ES2152930T3 (es) Utilizacion de carbonato de calcio poroso como material soporte de cultivo de celulas in vitro.
DE59308413D1 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
BR9305636A (pt) Composição compreendendo TCMTB em um portador sólido e métodos para fazer uma composição compreendendo TCMTB e um portador sólido e para impedir o crescimento de um microorganismo.
DE69832520D1 (de) Verwendung von konjugierten linoleinsäure zur behandlung von type ii diabetes
DE59708441D1 (de) Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten
BR9205903A (pt) Sistema de retardamento aperfeiçaodos para a liberação retardada de substancias valiosas medicinais e/ou biológicas a partir de um materialde suporte de depósito
ES2103369T3 (es) Derivados de lanolina como sustancias que aceleran la penetracion y su aplicacion en sustancias farmaceuticas u otras formulaciones que contienen sustancias biologicamente activas.
AU4836497A (en) Enhancing keratinocyte migration and proliferation
GB2324528A (en) Cytostatic hydroxamic acid derivatives
CO4600643A1 (es) Procedimiento de acondicionamiento de tejidos de vegetales cultivados en vitro y dispositivo para dicho acondicionamiento
NO20005724D0 (no) Biologisk aktiv sammensetning
ATE267401T1 (de) Technik zur mikroverkapselung von markierungen
EP0997735A3 (de) Stabilisierung von biologischen Flüssigkeiten durch Zusatz von Sterinestern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition